CVRx, Inc.
$7.24
▼
-0.99%
2026-04-21 06:19:01
www.cvrx.com
NMS: CVRX
Explore CVRx, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$193.65 M
Current Price
$7.24
52W High / Low
$11.3 / $4.3
Stock P/E
—
Book Value
$1.5
Dividend Yield
—
ROCE
-56.04%
ROE
-96.59%
Face Value
—
EPS
$-1.95
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
223
Beta
1.12
Debt / Equity
128.43
Current Ratio
7.63
Quick Ratio
6.72
Forward P/E
-4.03
Price / Sales
3.32
Enterprise Value
$163.06 M
EV / EBITDA
-3.23
EV / Revenue
2.88
Rating
None
Target Price
$11.17
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Biomerica, Inc. | $2.18 | — | $6.74 M | — | -122.16% | -84.3% | $4.6 / $1.87 | $1.5 |
| 2. | Pulmonx Corporation | $1.42 | — | $59.98 M | — | -49.13% | -77.19% | $5.46 / $1.13 | $1.3 |
| 3. | Avanos Medical, Inc. | $24.64 | — | $1.15 B | — | 1.7% | -9.07% | $24.72 / $9.3 | $16.75 |
| 4. | Profound Medical Corp. | $7.15 | — | $331 M | — | -57.78% | -67.11% | $12.4 / $5.23 | $1.83 |
| 5. | Integer Holdings Corporation | $89.32 | 29.89 | $3.07 B | — | 7.52% | 6.11% | $127.56 / $62 | $50.85 |
| 6. | Lumexa Imaging Holdings, Inc. | $9.65 | — | $928.42 M | — | 1.69% | -12.6% | $19.45 / $7.23 | $6.1 |
| 7. | Glaukos Corporation | $123.8 | — | $7.27 B | — | -25.2% | -26.38% | $130.23 / $73.16 | $11.41 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | |
|---|---|---|---|---|---|
| Sales | 16.02 M | 14.69 M | 13.59 M | 12.35 M | 15.34 M |
| Operating Profit | -11.18 M | -12.27 M | -14.38 M | -13.44 M | -10.27 M |
| Net Profit | -11.93 M | -12.87 M | -14.74 M | -13.77 M | -10.65 M |
| EPS in Rs | -0.45 | -0.49 | -0.56 | -0.52 | -0.4 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 56.65 M | 51.29 M | 39.3 M | 22.47 M |
| Operating Profit | -51.27 M | -59.49 M | -43.1 M | -42.53 M |
| Net Profit | -53.31 M | -59.97 M | -41.2 M | -41.43 M |
| EPS in Rs | -2.03 | -2.28 | -1.57 | -1.57 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 104.79 M | 133.41 M | 115.23 M | 124.94 M |
| Total Liabilities | 65.47 M | 62.36 M | 39.28 M | 15.76 M |
| Equity | 39.32 M | 71.06 M | 75.95 M | 109.18 M |
| Current Assets | 101.65 M | 129.81 M | 112.09 M | 122.88 M |
| Current Liabilities | 13.32 M | 10.76 M | 7.86 M | 8.09 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -40.17 M | -39.14 M | -39.02 M | -42.68 M |
| Investing CF | -0.58 M | -1.36 M | -0.59 M | -0.69 M |
| Financing CF | 10.52 M | 55.87 M | 23.98 M | 7.49 M |
| Free CF | -40.75 M | -40.51 M | -39.61 M | -43.36 M |
| Capex | -0.58 M | -1.36 M | -0.59 M | -0.69 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue Growth % | 10.45% | 30.53% | 74.89% | — |
| Earnings Growth % | 11.1% | -45.55% | 0.55% | — |
| Profit Margin % | -94.1% | -116.91% | -104.85% | -184.38% |
| Operating Margin % | -90.49% | -115.98% | -109.69% | -189.27% |
| Gross Margin % | 85.33% | 83.75% | 84.08% | 77.75% |
| EBITDA Margin % | -82.51% | -107.02% | -98.56% | -181.33% |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.